Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan vs Losartan in Hypertension (TOPAS)
NCT02200653Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2000
- Primary completion
- Feb 2001
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of telmisartan in hypertension (HTN) (4 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Change from baseline in mean diastolic blood pressure during the last 6 hours of the 24-hour dosing interval at 8 weeks. Started May 2000; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02200653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02200653.